March 15, 2023 — Windtree Therapeutics, Inc, a biotechnology company focused on advancing late-stage interventions for ...
March 14, 2023 — Royal Philips, a global leader in health technology, and the Gibraltar Health Authority, announced they ...
March 14, 2023 — The Society of Thoracic Surgeons (STS) has developed and launched a new risk calculator to estimate the ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
March 14, 2023 —MedAlliance has announced enrollment of over 1,000 patients in its ground-breaking SELUTION DeNovo ...
March 13, 2023 — BioCardia, Inc., developer of cellular and cell-derived therapeutics for the treatment of ...
March 13, 2023 — An enlarged heart, often described as left ventricular hypertrophy, is a sign of early cardiac damage ...
During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...
March 13, 2023 — iRhythm Technologies, Inc., a leading digital health company focused on creating trusted solutions that ...
March 12, 2023 — As part of its ongoing news coverage of ACC23, the DAIC/dicardiology.com editorial team has condensed ...
March 10, 2023 — The first evidence that exceeding the World Health Organization (WHO) ozone limit is associated with ...
Today, cloud-native analytics can automate data acquisition and synthesize complex data from multiple sources. Here, we ...
March 10, 2023 — Researchers found evidence of heart muscle inflammation in a small number of patients with acute ...
March 10, 2023 — Inari Medical, Inc., a medical device company with a mission to treat and transform the lives of ...
March 9, 2023 — People with a recent diagnosis of atrial fibrillation (AF), the most common irregular heart rhythm, have ...
Many cardiology departments face significant challenges meeting regulatory requirements, quality metrics, and ...
March 9, 2023 — An enlarged heart, often described as left ventricular hypertrophy, is a sign of early cardiac damage ...
March 9, 2023 — C. Noel Bairey Merz, MD, FACC, professor of cardiology and the director of the Barbra Streisand Women’s ...
March 9, 2023 — Positive results from a Mineralys Therapeutics study, the Target-HTN Phase 2 trial, demonstrated ...